Want to see TPST full AI Analyst Report?
Tempest Therapeutics (TPST) Hedge Fund Trading Activity
Trend: ▼ Hedge Funds Decreased Holdings by 0 Shares Last Quarter
Hedge Fund Holdings in TPST
Based on the 13F filings of 488 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 Brad Bolzon | Versant Venture Management, LLC | Not Changed | 0.00% | $299,447 | 0.18% | ||
| BlackRock, Inc. | Not Ranked | Not Changed | 0.00% | $43,365 | <0.01% |
FAQ
Which hedge funds hold Tempest Therapeutics?
Currently, no data Available
Are hedge funds buying or selling TPST?
In the last quarter hedge funds have Increased their holdings in Tempest Therapeutics by 0 shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Tempest Therapeutics stock?
Warren Buffet currently does not own shares in Tempest Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here